Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Early demonstrations that mice could be tolerized to transplanted tissues with short courses of immunosuppressive therapy and that with regard to tolerance to self, CD4+FOXP3+ regulatory T cells (Tregs) appeared to play a critical role, have catalyzed strategies to harness FOXP3-dependent processes to control rejection in human transplantation. This review seeks to examine the scientific underpinning for this new approach to finesse immunosuppression.

Original publication

DOI

10.1172/JCI67226

Type

Journal article

Journal

J Clin Invest

Publication Date

04/2014

Volume

124

Pages

1439 - 1445

Keywords

Animals, Epigenesis, Genetic, Forkhead Transcription Factors, Humans, Immunosuppression, Mice, Receptors, Antigen, T-Cell, Signal Transduction, T-Lymphocytes, Regulatory, Transplantation Tolerance